Search results
Researchers provide a review and update on therapy of gastrointestinal tract tumors
Medical Xpress· 4 days agoGastrointestinal (GI) cancers, encompassing esophageal, gastric, small bowel, and colorectal...
California Public Utilities Commission (CPUC) Rejects AT&T’s Request to Withdraw as Carrier of Last...
Sierra Sun Times· 2 days agoSAN FRANCISCO – The California Public Utilities Commission (CPUC), following extensive public input,...
WhatsApp spotted working on AR effects and filters for video calls
Neowin· 4 days agoWhatsApp is working on AR calling filters, avatars, and background effects for video calls. The...
Mosquito-fighting drone takes flight in South Florida, a ‘huge difference’ to keep insects at bay
Billings Gazette· 7 days agoFrom vast parks to wetlands to conservation areas, Broward County is now using a drone to spray for...
What's Going On With Workhorse Group Stock Monday? - Workhorse Gr (NASDAQ:WKHS)
Benzinga· 6 days agoWorkhorse Group Inc WKHS shares are in the spotlight Monday as the stock begins trading on a...
IBM’s InstructLab: A New Era For AI Model Creation And Performance
Forbes· 6 days agoIBM and Red Hat recently introduced InstructLab, a new AI training method for large language and...
Mosquito-fighting drone takes flight in South Florida, a ‘huge difference’ to keep insects at bay
The Times of Northwest Indiana· 7 days agoThe CDC calls mosquitoes the “world’s deadliest animal” because the diseases they transmit kill more...
Is Diageo plc (NYSE:DEO) the Best Large-Cap Alcohol Stock to Buy?
Insider Monkey via Yahoo Finance· 4 days agoWe recently compiled a list of the 10 Best Alcohol Stocks to Buy Now. Since Diageo plc (NYSE:DEO) is...
Big Tech Dominance: 5 Companies Projected To Lap Average S&P 500 Stock's Earnings Growth - SPDR S&P...
Benzinga· 3 days agoDespite the underperformance of several sectors, the SPDR S&P 500 ETF Trust SPY has already exceeded...
What's Going On With Small-Cap Cancer Focused XBiotech On Tuesday? - XBiotech (NASDAQ:XBIT)
Benzinga· 5 days agoTuesday, XBiotech Inc XBIT announced data from its Phase 1/Phase 2, 1-BETTER Study for advanced pancreatic cancer. The study examined the Natrunix (anti-interleukin-1alpha) antibody in combination ...